Payer Pressure Comes to Oncology
This article was originally published in RPM Report
Executive Summary
Why Payers Are Making Life Tougher for Oncology Marketers, and How Marketers Must Adapt.
You may also be interested in...
Are FDA And CMS Growing Apart? AEI’s Gottlieb Thinks So
While many pharmaceutical industry observers like to talk about the new ways in which FDA and CMS are working together and sharing information, Scott Gottlieb is offering a contrarian view on relations between the two agencies
GlaxoSmithKline Looks To Revamp U.S. Operations In Tough Environment
U.S. sales fell 13 percent in the third quarter due to generic competition and Avandia.
Pfizer Restructures For A More Flexible Future
In a move that could position Pfizer for more drastic measures down the road, the pharma giant has reorganized its development and commercial operations into several business units designed to foster autonomy and financial responsibility in the areas of specialty medicine, primary care and emerging markets